ABSTRACT DRUMMOND, MARGARET C. (Emory University, Atlanta, Ga.) AND MORRIS TAGER. Fibrinogen clotting and fibrino-peptide formation by staphylocoagulase and the coagulase-reacting factor. J. Bacteriol. 85:628-635. 1963.-The mechanism of fibrinogen clotting by staphylocoagulase and the coagulase-reacting factor (CRF) was studied from the standpoint of the products of the reaction, and compared with thrombin clotting of fibrinogen. Both clotting principles effect clotting with the release of nonprotein nitrogenous material, which can be resolved into three peptides by Dowex-50 chromatography. On the basis of the sedimentation constants, electrophoretic mobilities, and end-group analyses of these peptides, it appears that the products of fibrinogen clotting by coagulase-CRF and by thrombin are similar.
Since Loeb (1903) first demonstrated the clotting of goose plasma by staphylococci, considerable interest and study have centered around this phenomenon. It is now accepted that coagulase, derived from staphylococci, is capable of effecting the transformation of soluble fibrinogen to insoluble fibrin only in the presence of an accessory plasma factor, referred to as the coagulase-reacting factor (CRF). Little, however, is known regarding the chemical nature or the mechanism of action of the clotting principle produced when coagulase and CRF interact.
In spite of certain as yet unexplained differences, the analogy between the coagulase-CRF clotting principle and thrombin is striking, and has been strengthened by recent findings with purified materials. Like thrombin, and certain other proteins with coagulating capabilities, coagulase incubated with the plasma factor possesses esterase activity on a synthetic substrate, N-a-toluene-p-sulfonyl-L-arginine methyl ester (TAMe; Haughton and Duthie, 1959) . Like thrombin, coagulase-CRF is inhibited in its fibrinogen-clotting and TAMe-esterase activities by diisopropylfluorophosphate but is unaffected by soybean trypsin inhibitor (Drummond and Tager, 1962b) .
The chemical basis of thrombin action on fibrinogen has been extensively studied in recent years. Thrombin clotting is now generally accepted as being initiated by limited proteolysis, which cleaves from fibrinogen certain acidic peptides, and which renders the remainder of the fibrinogen molecule capable of secondary polymerization and gel formation (Scheraga and Laskowski, 1957) . Lorand (1952) demonstrated the release of nonprotein nitrogen from fibrinogen under the catalysis of thrombin, and others (Bailey and Bettleheim, 1955; Lorand and Middlebrook, 1952) showed that bovine fibrinogen possesses only glutamyl and tyrosyl N-terminal residues, whereas fibrin has tyrosyl and glycyl residues. Blomback and Vestermark (1958) successfully chromatographed the thrombin-induced fibrino-peptides.
The present studies deal with (i) the chemical isolation of the reaction products resulting from the interaction between the coagulase-CRF clotting principle and purified bovine fibrinogen, and (ii) a comparison of these products with those obtained from thrombin-catalyzed fibrinogen clotting. On the basis of the reaction products, an analogy is made between coagulase-CRF-induced and thrombin-induced clotting of fibrinogen.
MATERIALS AND METHODS Staphylocoagulase. Partially purified staphylocoagulase was prepared by the method of Tager (1948) . The material, at a protein concentration of approximately 2%, was homogeneous upon ultracentrifugation at 259,700 X g in a Spinco ultracentrifuge (model E), giving an uncorrected sedimentation constant of 1.36 X 10-13. Despite this apparent homogeneity, similar preparations have been shown to possess several enzymatic 628 activities Tager, 1959, 1962a) , suggesting the partial nature of their purification.
The final (NH4)2SO4 precipitate was subjected to a limited dialysis only, because of the lability of the purified coagulase, and was lyophilized. Clotting activity was assayed by adding 0.5 ml of noninhibitory plasma to 0.5 ml of serial twofold dilutions of coagulase in 2% peptone-saline (Merthiolated, 1:5,000). (Plasma was determined noninhibitory by the following procedure. Outdated blood-bank human plasma containing citrate, dextrose, and anticoagulant was assayed against a 5-day culture filtrate of Staphylococcus aureus strain 104 by adding 0.5 ml of plasma to 0.5 ml of doubling dilutions of the culture filtrate. Those plasmas which clotted the stock culture filtrate at dilutions in excess of 1:640 after overnight incubation at 38 C were considered noninhibitory.) The titer was taken as the reciprocal of the dilution of coagulase in the last tube showing a solid (invertible) clot after incubation at 38 C for 24 hr. The coagulase preparation employed throughout these studies had a clotting titer of 2,048 per mg of lyophilized powder, or 40,960 per mg of protein.
Coagulase-reacting factor. CRF was purified from outdated blood-bank human plasma by the column chromatographic method (Tager, 1956) . After limited dialysis and lyophilization, the preparations employed in these studies contained 4.5 and 8.6% and 7.4 and 9.2% prothrombin as assayed by the conventional two-stage prothrombin method (Wagner et al., 1955) . Thrombin contamination was negligible.
Fibrinogen. Armour fraction I bovine fibrinogen was further purified by (NH4)2SO4 precipitation (Laki, 1951 (Gladner et al., 1959) .
Ultracentrifuge studies. For analysis by ultracentrifugation, the peptide materials were dried at 30 C by use of a Rinco flash evaporator. The temperature of the water bath was then raised to 40 C and maintained for several hours, to rid the peptide material of excess ammonium acetate. The sample was then dissolved in 0.1 M acetate buffer (pH 4.8). Measurements were made in a Spinco analytical ultracentrifuge (model E), using a synthetic boundary cell.
Analysis of N-terminal amino acids. The fluorodinitrobenzene method of Sanger (1945) was employed for the determination of the N-terminal amino acids of the clot-induced peptides. The peptides (1 to 5 mg) were dissolved in 0.2 M (NH4)2CO3 and placed in reaction with an ethanolic solution of fluorodinitrobenzene (FDNB; 2.5%, v/v) at 40 C for 2 to 4 hr. After ether extraction to remove excess FDNB, and overnight lyophilization, the dried material was hydrolyzed with constantly boiling HCl at 105 C in an electric autoclave (American Sterilizer Co., all-purpose junior autoclave) for periods of 4 and 24 hr. The dinitrophenyl (DNP)-labeled amino acids were extracted by ether and further freed from contaminating FDNB degradation products by sublimation, using a cold finger apparatus, Dry Ice, and a water bath at 60 C. The DNPamino acids were identified by two-dimensional paper chromatography, employing the toluenepyridine-chloroethanol solvent and 1.5 M phosphate recommended by Fraenkel-Conrat, Harris, and Levy (1958) .
RESULTS
Preparation of peptide mixture derived from fibrinogen clotting by coagulase-CRF. For clotting, the fibrinogen concentration was adjusted to 1 %, and the ionic strength of the KCl diluent to 0.15.
The resulting pH was 6.7. The solution was warmed to 38 C prior to the addition of the clotting agents.
Coagulase (712 mg of protein) and CRF (177 mg of protein) were each dissolved separately in 30 ml of 0.067 M phosphate buffer (pH 6.8) and warmed to 38 C. The two solutions were subsequently mixed and incubated for 20 min for maximal generation of the clotting principle (Haughton and Duthie, 1959) .
The entire contents of the coagulase-CRF mixture were then added to 900 ml of the 1% fibrinogen, mixed, and incubated at 38 C. The solution became opaque in approximately 3 min, and semisolid in 6 min. Incubation was continued for 30 min post-clotting, to ensure the maximal liberation of fibrino-peptides (Lorand, 1952) .
After coagulation was complete, the solid clot was cut into smaller pieces and homogenized briefly in a Waring Blendor. Upon subsequent centrifugation, the fibrin packed solidly at the top of the centrifuge tubes and could be removed with a spatula, leaving the clear clot liquor beneath.
The proteins of the clot liquor were precipitated by the addition of one-fourth volume of 40% trichloroacetic acid. After gravity filtration (Whatman no. 2 paper), the clear filtrate was extracted with diethyl ether to remove the trichloroacetic acid. Preliminary hand extraction was followed by continuous cold liquid-liquid extraction for 8 to 16 hr. After extraction, the clear filtrate was taken to dryness on a Rinco flash evaporator, at a temperature never iD excess of 27 to 28 C. The residue was reconstituted with 0.1 M ammonium formate buffer (pH 3.5) preparatory to chromatography.
Removal of salts from the clot liquor. Column chromatography was employed to remove the nonvolatile salts present in the clotting mixture. A column (5 by 15 cm) of Dowex-50 X 2 ionexchange resin, in the ammonium form, was equilibrated with 0.1 M ammonium formate (pH 3.2). After addition of the clot material, the column was washed with 1 liter of 0.1 M ammonium formate (pH 3.5) to remove the remaining nonvolatile salts. The protein content of this wash was essentially negative. The peptides were eluted from the column with 0.2 M ammonium acetate (pH 5.1), 10-ml fractions being collected on an automatic fraction collector at a rate of 5 ml per min. The nonprotein nitrogenous material was collected without loss in a volume of approximately 240 ml. Prior to separation chromatography, this material was evaporated as before, and reconstituted in 0.1 M formate (pH 3.2).
Resolution of the fibrino-peptides by column chromatography. A Dowex-50 X 2 ion-exchange resin column (2 by 45 cm), equilibrated with Fig. 1 , the yields of peptides E, Al, A2, and B were 5.8, 22.0, 11.5, and 24.1 mg of protein, respectively.
Preparation of thrombin-inducedfibrino-peptides.
For purposes of comparison, fibrino-peptides derived from the clotting of fibrinogen by thrombin were prepared under conditions essentially similar to those described by Blombaick and Vestermark (1958) . Clotting was accomplished by the addition of bovine thrombin (commercial product, The Upjohn Co., Kalamazoo, Mich.) at a final concentration of 1 unit per ml to 0.7% purified fibrinogen at pH 7.3 and 38 C. After clot retraction, trichloroacetic acid precipitation and ether extraction of the clot liquor were carried out as described in detail above for the coagulase-CRF system. Column chromatographic separation of the resulting material, employing the conditions described, confirmed the findings of Blombiick and Vestermark. Figure 2 shows the elution diagram of thrombin-induced fibrinopeptides from a Dowex-50 X 2 column. Three peptides (E, A, and B) can be seen which resemble, in their chromatographic behavior, those described by Blombiick and Vestermark (1958) .
Comparison of the elution diagrams of the fibrino-peptides released from fibrinogen by thrombin and by the coagulase-CRF clotting principle reveals the presence of an additional peptide (A2) component in the latter system. In three separate experiments, this additional component was consistently present, but varied somewhat in concentration and extent of separation from the adjacent peptide peak (Al).
It was essential to determine whether the additional (A2) peptide in the coagulase-CRF clot liquor arose from the clotting reaction itself or originated in the participating proteins. Although all the proteins involved in the clotting reaction had been dialyzed prior to use, the degree of dialysis was limited by the lability of the materials. Also, since the reacting factor is purified from plasma and is known to possess traces of prothrombin and thrombin, it was necessary to determine whether the concentrations of these contaminating materials alone were sufficient to react with fibrinogen in the absence of coagulase with the release of peptides.
A control experiment was carried out with reactions of identical concentrations of the same preparations of reacting factor and fibrinogen, under conditions of time and temperature identical to those described above. There were no visible evidences of clotting, even after incubation of the reacting factor-fibrinogen mixture at 38 C. Notwithstanding the absence of visible clotting, the mixture was subjected to the same conditions of blending, protein precipitation, ether extraction, and concentration as the solid-clot materials had been in previous experiments. Figure 3 shows the column-chromatographic It is thus apparent that the "additional" peptide seen to result from coagulase-CRF-catalyzed fibrin formation is inherently not a specific product of the reaction but represents either a contaminating material initially present in one of the reactants, or a product of the action of partially purified reacting factor on fibrinogen. Ultracentrifugal analysis. The coagulase-CRFinduced fibrino-peptides were reconstituted in 0.1 M acetate buffer (pH 4.8) at a concentration of 0.5 to 1.0% protein for analysis in the synthetic boundary cell of a Spinco ultracentrifuge (model E) at 259,700 X g. The sedimentation diagrams (Fig. 4) * Sedimentation constant values of coagulase-CRF peptides were calculated on 0.5 to 1.0% protein concentration in 0.1 M ammonium acetate (pH 4.8). Values for thrombin peptides as (Sn') from Gladner et al. (1959). geneity. A comparison of the sedimentation constants in these peptides with those of thrombininduced peptides are shown in Table 1 . The molecular weights of the thrombin peptides, calculated from sedimentation and diffusion values, are included for purposes of comparison. Insufficient material in these studies prevented the determination of molecular weights of the coagulase-CRF-induced peptides.
Paper electrophoresis. Electrophoresis of the coagulase-CRF-induced fibrino-peptides was carried out employing a Spinco paper electrophoresis apparatus, Whatman no. 3 MM paper, and 0.1 M phosphate buffer (pH 7.0). Samples of peptides A and B, as well as of the original unresolved clot liquor, were applied to 3-cm paper strips and run at room temperature (22 C) for 16 hr at a potential gradient of 9.2 v per cm-l width. After electrophoresis, the strips were dried and either sprayed with or dipped into a solution of 0.25% ninhydrin in acetone-5% acetic acid (v/v; Gladner et al., 1959) . From Fig. 5 , it can be seen that all peptides move toward the anode, the A peptides possessing greater mobilities than the B peptide. The two peptides A (1 and 2) failed to be resolved by this technique. VOL. 85, 1963 applied to the fractionated peptides resulting from the clotting of fibrinogen by coagulase-CRF. After two-dimensional chromatography, both peptides Al and A2, as well as peptide E, revealed glutamic acid as their single N-terminal amino acid. Peptide B failed to show any N-terminal amino acid, despite repeated attempts with several concentrations of the peptide. End-group analyses made on fibrino-peptides subsequently derived from two independent experiments confirmed these findings. Bettleheim (1956) , using the FDNB method of Sanger, and Blomback (1958) , employing the Edman phenylthiohydantoin method, independently determined the N-terminal amino acids of the thrombin-catalyzed fibrino-peptides, A and B. Peptide A contained glutamic acid as its sole N-terminal amino acid, whereas no N-terminal amino acid could be demonstrated for peptide B. These findings were later fully substantiated (Folk et al., 1959a; Sjoquist, Blombiick, and Wallen, 1960) when degradation studies and sequential analyses were performed on the thrombin-induced peptides A and B. The structure of peptide A was completely elucidated, whereas that of peptide B was only partially determined, due to the uncertainties regarding its N-terminal end. Sjoquist suggested that the failure of peptide B to reveal a free N-terminal amino acid may be due to the presence of either an interfering adjacent radical or a ring structure involving the N-terminal end of the molecule.
DISCUSSION
The question of whether thrombin clotting of fibrinogen involves proteolysis, much argued for many years, has recently been resolved on a firm chemical basis. Mihalyi (1950) reported differences in the electrophoretic mobilities of fibrinogen and fibrin when both are dissolved in urea, and Lorand (1952) demonstrated that limited proteolysis accompanies the transformation of fibrinogen to fibrin by showing a 3% increase in nonprotein nitrogen during the reaction. Independent work by others (Bailey and Bettleheim, 1955; Lorand and Middlebrook, 1952) established the fact that the glutamic acid N-terminal residues present in fibrinogen give rise to glycine in fibrin when the clotting of purified fibrinogen occurs. The glutamic acid was recoverable as the N-terminal amino acid of a peptide fraction split off during the transformation. The cleaved peptide material presumably represented the 3% nonprotein nitrogen fraction reported by Lorand.
Recent work (Blomback and Vestermark, 1958; Folk et al., 1959b) has demonstrated the presence of two peptides (A and B) in this nonprotein nitrogen fraction intimately related to the clotting process, and has elucidated their amino acid sequences (Sj6quist et al., 1960) . The exact nature and origin of the peptide E, demonstrated only under the conditions of Dowex-50 chromatography described by Blomback and Vestermark, is unknown. Blombiack and Vestermark suggested that it may be "a contaminant of the fibrinogen preparation or ... a denaturation product of the peptides." It is of interest that peptide E was also seen in the present studies on coagulase-CRF clotting. Its relation to the clotting reaction seems questionable, in view of the fact that it is not apparent by diethylaminoethylcellulose chromatography, which successfully separates peptides A and B (Folk et al., 1959a, b In the present study, we examined the reaction between fibrinogen and the coagulase-CRF clotting principle with regard to the composition of the nonprotein nitrogen material released when clotting occurs, for the purpose of establishing the relationship of this reaction to thrombin clotting. From this viewpoint, it appears that the two reactions are similar. Both effect clotting by a preliminary proteolysis which results in the liberation of two peptides, A and B. Sedimentation studies, electrophoresis, and end-group analysis fail to distinguish between the peptides A, or between the peptides B, derived from the action of the two clotting principles on fibrinogen.
